These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16516980)

  • 1. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
    Khalil M; Reindl M; Lutterotti A; Kuenz B; Ehling R; Gneiss C; Lackner P; Deisenhammer F; Berger T
    J Neuroimmunol; 2006 May; 174(1-2):147-56. PubMed ID: 16516980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.
    Menge T; von Büdingen HC; Lalive PH; Genain CP
    Eur J Immunol; 2007 Nov; 37(11):3229-39. PubMed ID: 17918203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
    Ichikawa M; Johns TG; Liu J; Bernard CC
    J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice.
    Ichikawa M; Koh CS; Inaba Y; Seki C; Inoue A; Itoh M; Ishihara Y; Bernard CC; Komiyama A
    Cell Immunol; 1999 Feb; 191(2):97-104. PubMed ID: 9973531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of antibodies against myelin oligodendrocyte glycoprotein in different clinical types of multiple sclerosis.
    Zadro I; Brinar V; Horvat G; Brinar M
    Clin Neurol Neurosurg; 2007 Jan; 109(1):23-6. PubMed ID: 16750597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
    Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
    Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
    Mendel Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
    Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY
    Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients.
    Breij EC; Heijnen P; van der Goes A; Teunissen CE; Polman CH; Dijkstra CD
    J Neuroimmunol; 2006 Jul; 176(1-2):106-14. PubMed ID: 16712958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
    Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
    Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination.
    von Büdingen HC; Hauser SL; Ouallet JC; Tanuma N; Menge T; Genain CP
    Eur J Immunol; 2004 Aug; 34(8):2072-83. PubMed ID: 15259004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
    Haase CG; Guggenmos J; Brehm U; Andersson M; Olsson T; Reindl M; Schneidewind JM; Zettl UK; Heidenreich F; Berger T; Wekerle H; Hohlfeld R; Linington C
    J Neuroimmunol; 2001 Mar; 114(1-2):220-5. PubMed ID: 11240035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies.
    Abo S; Bernard CC; Webb M; Johns TG; Alafaci A; Ward LD; Simpson RJ; Kerlero de Rosbo N
    Biochem Mol Biol Int; 1993 Aug; 30(5):945-58. PubMed ID: 8220243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
    Rauer S; Euler B; Reindl M; Berger T
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):739-42. PubMed ID: 16705196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.